ArticleERJ open research2025

Mepolizumab in patients with severe asthma and blood eosinophil counts between 150 and 300 cells per µL: benefits at two years.

Giorgio W Canonica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.